Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Prednisone × Clear all

Phase

Status

Completed 11 Active not recruiting 6 Terminated 5 Recruiting 5 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 22 Lymphoma 11 Lymphoma, Non-Hodgkin 8 Prostatic Neoplasms 7 Lymphoma, T-Cell, Peripheral 7 Lymphoma, Follicular 7 Leukemia 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Neoplasms, Plasma Cell 4 Lymphoma, Mantle-Cell 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myasthenia Gravis 2 Lymphoma, Large-Cell, Immunoblastic 2 Immunoblastic Lymphadenopathy 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Spinal Cord Neoplasms 1 Recurrence 1 Plasmablastic Lymphoma 1 Neoplasms, Experimental 1 Neoplasms 1 Neoplasm Metastasis 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Neoadjuvant Therapy 1 Myelodysplastic Syndromes 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1

Interventions

Exercise 15 Drug Therapy 15 Capecitabine 10 Blood Specimen Collection 10 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Cyclophosphamide 5 Cisplatin 5 atezolizumab 4 Therapeutics 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4 Injections 4 Gemcitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡